{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Clinical Lab Chat","title":"Alpha-Synuclein: Adding Precision to Neurodegenerative Testing","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/ef1a644f\"></iframe>","width":"100%","height":180,"duration":1443,"description":"In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, discusses the how and why of making precise clinical diagnosis of neurodegenerative diseases with Russ Lebovitz, MD, PhD, co-founder and CEO of Amprion.\n \nAmong the topics they discuss:\nThe critical importance of making accurate diagnoses of neurodegenerative diseases\nWhy alpha-synuclein is an accurate biomarker for a number of degenerative diseases, including Alzheimer’s\nHow adding neurodegenerative testing to the routine diagnostic menu would benefit patients and their caregivers\nWhy we’re entering a neurological healthcare “golden age”","thumbnail_url":"https://img.transistorcdn.com/tufk3X-Gxx2xn3K2zoupAtyj7GTQZyUUKf-riXddPoM/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQ0MzA4LzE2OTQw/OTgxOTctYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}